354 related articles for article (PubMed ID: 27814645)
1. Racial disparities in prostate cancer: a molecular perspective.
Bhardwaj A; Srivastava SK; Khan MA; Prajapati VK; Singh S; Carter JE; Singh AP
Front Biosci (Landmark Ed); 2017 Jan; 22(5):772-782. PubMed ID: 27814645
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer health disparities: An immuno-biological perspective.
Kumar S; Singh R; Malik S; Manne U; Mishra M
Cancer Lett; 2018 Feb; 414():153-165. PubMed ID: 29154974
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis for prostate cancer racial disparities.
Singh SK; Lillard JW; Singh R
Front Biosci (Landmark Ed); 2017 Jan; 22(3):428-450. PubMed ID: 27814623
[TBL] [Abstract][Full Text] [Related]
4. Pan-cancer clinical and molecular analysis of racial disparities.
Lara OD; Wang Y; Asare A; Xu T; Chiu HS; Liu Y; Hu W; Sumazin P; Uppal S; Zhang L; Rauh-Hain JA; Sood AK
Cancer; 2020 Feb; 126(4):800-807. PubMed ID: 31730714
[TBL] [Abstract][Full Text] [Related]
5. Integrative comparison of the genomic and transcriptomic landscape between prostate cancer patients of predominantly African or European genetic ancestry.
Yuan J; Kensler KH; Hu Z; Zhang Y; Zhang T; Jiang J; Xu M; Pan Y; Long M; Montone KT; Tanyi JL; Fan Y; Zhang R; Hu X; Rebbeck TR; Zhang L
PLoS Genet; 2020 Feb; 16(2):e1008641. PubMed ID: 32059012
[TBL] [Abstract][Full Text] [Related]
6. Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.
Yamoah K; Lee KM; Awasthi S; Alba PR; Perez C; Anglin-Foote TR; Robison B; Gao A; DuVall SL; Katsoulakis E; Wong YN; Markt SC; Rose BS; Burri R; Wang C; Aboiralor O; Fink AK; Nickols NG; Lynch JA; Garraway IP
JAMA Netw Open; 2022 Jan; 5(1):e2144027. PubMed ID: 35040965
[TBL] [Abstract][Full Text] [Related]
7. Racial disparities in prostate cancer: A complex interplay between socioeconomic inequities and genomics.
Lowder D; Rizwan K; McColl C; Paparella A; Ittmann M; Mitsiades N; Kaochar S
Cancer Lett; 2022 Apr; 531():71-82. PubMed ID: 35122875
[TBL] [Abstract][Full Text] [Related]
8. Health inequity drives disease biology to create disparities in prostate cancer outcomes.
Nelson WG; Brawley OW; Isaacs WB; Platz EA; Yegnasubramanian S; Sfanos KS; Lotan TL; De Marzo AM
J Clin Invest; 2022 Feb; 132(3):. PubMed ID: 35104804
[TBL] [Abstract][Full Text] [Related]
9. Racial differences in prostate cancer treatment outcomes: a systematic review.
Peters N; Armstrong K
Cancer Nurs; 2005; 28(2):108-18. PubMed ID: 15815180
[TBL] [Abstract][Full Text] [Related]
10. Racial disparities: disruptive genes in prostate carcinogenesis.
Singh S; Plaga A; Shukla GC
Front Biosci (Schol Ed); 2017 Jun; 9(2):244-253. PubMed ID: 28410117
[TBL] [Abstract][Full Text] [Related]
11. Prostate Cancer in African American Men: The Effect of Androgens and microRNAs on Epidermal Growth Factor Signaling.
Nwaneri AC; McBeth L; Hinds TD
Horm Cancer; 2016 Dec; 7(5-6):296-304. PubMed ID: 27447901
[TBL] [Abstract][Full Text] [Related]
12. A CD24-p53 axis contributes to African American prostate cancer disparities.
Liu W; Zhang Y; Wei S; Bae S; Yang WH; Smith GJ; Mohler JL; Fontham ETH; Bensen JT; Sonpavde GP; Chen GY; Liu R; Wang L
Prostate; 2020 May; 80(8):609-618. PubMed ID: 32168400
[TBL] [Abstract][Full Text] [Related]
13. MiRNA 26a expression in a novel panel of African American prostate cancer cell lines.
Theodore SC; Rhim JS; Turner T; Yates C
Ethn Dis; 2010; 20(1 Suppl 1):S1-96-100. PubMed ID: 20521394
[TBL] [Abstract][Full Text] [Related]
14. Genetic and molecular differences in prostate carcinogenesis between African American and Caucasian American men.
Farrell J; Petrovics G; McLeod DG; Srivastava S
Int J Mol Sci; 2013 Jul; 14(8):15510-31. PubMed ID: 23892597
[TBL] [Abstract][Full Text] [Related]
15. Germline Mutations in African American Men With Prostate Cancer: Incidence, Implications and Diagnostic Disparities.
Bree KK; Hensley PJ; Pettaway CA
Urology; 2022 May; 163():148-155. PubMed ID: 34453957
[TBL] [Abstract][Full Text] [Related]
16. Minireview: the molecular and genomic basis for prostate cancer health disparities.
Powell IJ; Bollig-Fischer A
Mol Endocrinol; 2013 Jun; 27(6):879-91. PubMed ID: 23608645
[TBL] [Abstract][Full Text] [Related]
17. Associations between RNA splicing regulatory variants of stemness-related genes and racial disparities in susceptibility to prostate cancer.
Wang Y; Freedman JA; Liu H; Moorman PG; Hyslop T; George DJ; Lee NH; Patierno SR; Wei Q
Int J Cancer; 2017 Aug; 141(4):731-743. PubMed ID: 28510291
[TBL] [Abstract][Full Text] [Related]
18. Ultraviolet index and racial differences in prostate cancer incidence and mortality.
Taksler GB; Cutler DM; Giovannucci E; Smith MR; Keating NL
Cancer; 2013 Sep; 119(17):3195-203. PubMed ID: 23744754
[TBL] [Abstract][Full Text] [Related]
19. Racial disparities in prostate cancer among black men: epidemiology and outcomes.
Chowdhury-Paulino IM; Ericsson C; Vince R; Spratt DE; George DJ; Mucci LA
Prostate Cancer Prostatic Dis; 2022 Sep; 25(3):397-402. PubMed ID: 34475523
[TBL] [Abstract][Full Text] [Related]
20. Comparison of germline mutations in African American and Caucasian men with metastatic prostate cancer.
Ledet EM; Burgess EF; Sokolova AO; Jaeger EB; Hatton W; Moses M; Miller P; Cotogno P; Layton J; Barata P; Lewis BE; Nakazawa M; Zhu J; Dellinger B; Elrefai S; Nafissi NN; Egan JB; Shore N; McKay RR; Bryce AH; Cheng HH; Antonarakis ES; Sartor O
Prostate; 2021 May; 81(7):433-439. PubMed ID: 33792945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
